Albino Claudio Bosio

Uno sguardo al percorso attuale e prospettico della Rivista: (III) Implementazioni

Albino Claudio Bosio

P13.14.A REGORAFENIB VERSUS LOCAL STANDARD OF CARE IN PATIENTS WITH GRADE 2-3 MENINGIOMA NO LONGER ELIGIBLE FOR LOCO-REGIONAL TREATMENTS: THE MIRAGE TRIAL

Albino Claudio Bosio, Giulia Cerretti, Marta Padovan, Paola Del Bianco et autres

it, ua (code pays fourni par la source)

P12.32.A MOLECULAR STRATIFICATION BY PTEN STATUS REVEALS DIFFERENTIAL SECOND-LINE THERAPY RESPONSES IN RECURRENT IDH-WILDTYPE GLIOBLASTOMA

Eugenia Cella, Marta Padovan, E Marchesani, Albino Claudio Bosio et autres

it, by, ua (code pays fourni par la source)

P12.21.B A PHASE 1, FIRST-IN-HUMAN STUDY OF REGORAFENIB PLUS TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED, IDH WILDTYPE GLIOBLASTOMA: REGOMA-2 TRIAL

Marta Padovan, Matteo Simonelli, Amedeo De Nicolò, Paola Del Bianco et autres

it, by (code pays fourni par la source)

P03.07.B STRUCTURAL CONNECTIVITY-BASED SPREADING PATTERNS OF MULTIFOCAL AND MULTICENTRIC GLIOMAS

G. Sansone, Lauriane Pini, D Mirkarimi, Valentina Baro et autres

it (code pays fourni par la source)

P17.40.B EFFECTIVENESS OF TARGET THERAPY IN ADULT AND PEDIATRIC RECURRENT HIGH GRADE GLIOMA PATIENTS WITH BRAFV600E MUTATION OR NTRK FUSION: A REAL-LIFE MULTICENTRIC ITALIAN ANALYSIS.

Eugenia Cella, Matteo Padovan, Albino Claudio Bosio, M Maccari et autres

it, my (code pays fourni par la source)

714eP Medulloblastoma diagnosis in adults: A monocentric retrospective experience

G. Cerretti, M. Padovan, M. Caccese, M. Maccari et autres

it (code pays fourni par la source)

Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab

Irene Vanni, Michela Croce, Lorenza Pastorino, E. Allavena et autres

it (code pays fourni par la source)

Uno sguardo al percorso attuale e prospettico della Rivista: (II) Linea editoriale

Albino Claudio Bosio

Uno sguardo al percorso e alle prospettive di percorso della Rivista: (I) Governance

Albino Claudio Bosio

P18.34.A PTEN ALTERATION AS A PREDICTOR OF SECOND-LINE EFFICACY IN PATIENTS WITH RECURRENT IDHWT-GLIOBLASTOMA

Eugenia Cella, Maurizio Polano, Matteo Padovan, Albino Claudio Bosio et autres

it (code pays fourni par la source)

P20.15.B MOLECULAR CHARACTERIZATION OF ADULT NON-GLIOBLASTOMA CENTRAL NERVOUS SYSTEM (CNS) TUMORS TO IDENTIFY POTENTIAL TARGETTABLE ALTERATIONS

Matteo Padovan, Albino Claudio Bosio, Eugenia Cella, M Maccari et autres

it (code pays fourni par la source)